BMT Adverse Reactions/Management Flashcards

1
Q

Hemorrhagic cystitis

A

inflammatory condition of urinary bladder with sudden onset of hematuria, bladder pain, irritative bladder symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hemorrhagic cystitis management with Cytoxan (4)

A
  1. Hyperhydration - TO BE STARTED NIGHT BEFORE CYTOXAN IS ADMINISTERED and again 6-12h post infusion
  2. Monitor UAs specific gravity (need SG to be <1.010 to start Cytoxan, if >1.010 then give 10cc/kg bolus NS)
  3. MESNA- to be given with high dose Cytoxan, acts to neutralize acrolein
  4. Ensure voiding q2h x 24h after Cytoxan admin (may require foley catheter or bladder irrigation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hyperhydration with Cytoxan/hemorrhagic cystitis

A

125mL/m2/hr of D5NS or D5 1/2 NS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SIADH

A

Syndrome of inappropriate anti-diuretic hormone; causes hyponatremia (though urine Na is high) and decreased bladder output (low sodium and low urine output)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SIADH treatment

A

Lasix & fluid restrictions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SIADH Prevention (6)

A
  1. strict Is&Os
  2. monitor specific gravity/UAs
  3. daily weights
  4. PRN lasix
  5. NS boluses
  6. Chem10 - monitor Na
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cardiotoxicity with Cytoxan prophylaxis

A

Order EKG prior to each dose and look for early evidence of decreased QRS voltage or T wave changes which may indicate early cardiotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Busulfan and hepatotoxicity (4: risk factors, management, ppx, treatment)

A
  1. Risk factors: Fe overload, abnormal LFTs, previous chemo, previous abdominal radiotherapy
  2. Monitor: weight, LFTs, I&Os, abd circumference, liver size
  3. Prophylaxis: Ursodiol/Actigall
  4. Treatment: defibrotide to treat VOD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Busulfan seizure ppx

A

Anti-convulsant, usually Ativan, give during Bu administration and 48h after; if it is a sickle cell patient, use Keppra (30mg/kg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Thiotepa and skin changes management (3)

A
  1. Frequent baths by RN
  2. Minimal dressings and wear loose clothing
  3. Protective gear
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PRES (posterior reversible encephalopathy syndrome)

A
CAUTION WITH TACROLIMUS LEVELS >15
1. Headache
2. HTN*** (give hydralazine)
3. Vision changes
4. Changes in mental status
5. Seiures 
If concerns - stop IV or PO med
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Emergency meds to have at bedside on day 0

A
  1. Tylenol
  2. Benadryl
  3. Hydrocort - do not use with CAR-T or haplo
  4. Lasix
  5. Epinepherine
  6. Albuterol
  7. Hydralazine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Day 0 pearls if s/e (5)

A
  1. If patient has any type of reaction, stop infusion and then restart at slower rate
  2. If hypertension –> pause infusion; suspect fluid overload then give Lasix. If need immediate relief or BP not lowering, give hydralazine –> restart at 1/2 rate
  3. If coughing –> check for wheezing, pause, give albuterol, then once resolved restart at slower rate
  4. If hives –> Benadryl –> hydrocort if not resolving
  5. Complaints of itchy throat/closing –> epinepherine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

VOD

A

When the small blood vessels that lead to or are inside the liver become damaged or blocked
Increased risk with busulfan, TBI and other chemo agents b/c they damage the endothelial cells (can act on CD33 expressed by liver cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

VOD pathophysiology (5 steps)

A

1st: Damage to endothelium
2nd: Leakage
3rd: Clot formation (activation of coagulation cascade by leakage)
4th: Clot of bile ducts
5th: Reversal of flow, pain, ascites (fluid collected in abd)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

S/S of VOD (6)

A

Hepatosplenomegaly, ascites, weight gain, increased bilirubin, jaundice

17
Q

Labs with VOD (3)

A
  1. Elevated D dimer
  2. Elevated bili
  3. Low platelets
18
Q

Diagnosis of VOD

A

Abdominal u/s with doppler to assess for reversal of flow

19
Q

Diagnostic criteria of VOD (Seattle criteria, 3)

A

Presentation by day 20 post HSCT of at least two of the following:

  1. Bili > 2mg/dL
  2. Hepatomegaly or RUQ pain
  3. Weight gain >2%
20
Q

Treatment of VOD

A

DEFIBROTIDE 6.25mg/kg IV q6 (antithrombotic that breaks up clots) & give concentrated IVF

21
Q

BK Virus

A

A common virus that may become reactivated after transplant; can be in blood, bladder/kidney
May cause UTI type symptoms or hemorrhagic cystitis

22
Q

Treatment for BK virus (4)

A
  1. If hemorrhagic cystitis: keep plt >50
  2. If pain: Pyridium x 3 days and ditropan indefinitely (Bladder relaxant)
  3. Hyperhydration to dilute RBCs and avoid clots
  4. For mild or refractory illness: cidofovir IV weekly (dose higher if refractory)
23
Q

GVHD

A

When the donor’s cells attack the recipient’s body

acute: <100 days from transplant
chronic: >100 days from transplant

24
Q

GVHD Treatment

A

Methylpred 2mg/kg IV

2nd line: jakafi

25
Q

Diagnosis of PRES

A

STAT CT - will show white matter edema in both hemispheres

26
Q

Parameters to give Defibrotide for VOD treatment (3)

A
  1. Plt <30
  2. INR <2.5
  3. Fibrinogen >150
27
Q

Gut GVHD symptoms and dx

A

Large amounts of diarrhea (may have serum protein in it), nausea, anorexia
Dx: biopsy

28
Q

Skin GVHD

A

Acute erythematous rash, typically on palms of hands and soles of feet, may also present around neck, back, arms
Dx via skin biopsy

29
Q

Liver GVHD

A

Increased total bili; do percutaneous or transjuglar biopsy